Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Clinical trial NCT00000626 · COMPLETED
Trial details
- NCT number
- NCT00000626
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.